Episode 2: Defy Single-Cell Gravity: Escape Platform Constraints With QuantumScale and ScalePlex

Archana Bettadapur – Product Manager – Scale Biosciences Archana is a product manager at Scale Biosciences, supporting development of new and on-market research tools for transcriptomics and epigenomics. She has held several cross functional positions across medical devices, diagnostics, and genomics industries. Defy Single Cell Gravity: Escape Platform Constraints with QuantumScale and ScalePlex Single Cell RNA Sequencing methods have paved the way for discovery in many areas of research, and have provided a rich picture of the intrinsic heterogeneity of cell populations. However, current technological limitations have required trade-offs between depth, scale, and cost. Scale Bio has introduced a novel scRNA-seq platform, QuantumScale, and sample multiplexing method, ScalePlex, which enable high-throughput single cell sequencing without compromising on breadth or depth of analysis. QuantumScale Single Cell RNA is ideal for disease modeling and screening, population studies, and tissue atlasing efforts that have been constrained due to project complexity or cost. With the ability to fix and store samples, you can process multiple timepoints, individuals, or conditions together, saving time and minimizing batch effects. This unique technology enables deeper cellular insights, where finally you can design your experiments based on biological questions rather than technical constraints – whether you need to profile rare cell populations, capture subtle transcriptional changes, or analyze thousands or millions of cells simultaneously.